Tenofovir alafenamide/tenofovir disoproxil fumarateAcute tubular necrosis: case report

被引:0
|
作者
机构
关键词
D O I
10.1007/s40278-021-00845-2
中图分类号
学科分类号
摘要
引用
收藏
页码:388 / 388
相关论文
共 50 条
  • [22] Is Tenofovir Alafenamide Safer than Tenofovir Disoproxil Fumarate for the Kidneys?
    Aloy, Blandine
    Tazi, Imane
    Bagnis, Corinne Isnard
    Gauthier, Marion
    Janus, Nicolas
    Launay-Vacher, Vincent
    Deray, Gilbert
    Tourret, Jerome
    AIDS REVIEWS, 2016, 18 (04) : 184 - 192
  • [23] Tenofovir alafenamide (TAF) as the successor of tenofovir disoproxil fumarate (TDF)
    De Clercq, Erik
    BIOCHEMICAL PHARMACOLOGY, 2016, 119 : 1 - 7
  • [24] A Review and Clinical Understanding of Tenofovir: Tenofovir Disoproxil Fumarate versus Tenofovir Alafenamide
    Wassner, Chanie
    Bradley, Nicole
    Lee, Yuman
    JOURNAL OF THE INTERNATIONAL ASSOCIATION OF PROVIDERS OF AIDS CARE, 2020, 19
  • [28] Switching tenofovir disoproxil fumarate to tenofovir alafenamide not only bone and kidney
    Berger, F.
    Milinkovic, A.
    Arenas-Pinto, A.
    Mauss, S.
    ANTIVIRAL THERAPY, 2018, 23 : A48 - A48
  • [29] RENAL AND BONE SAFETY OF TENOFOVIR ALAFENAMIDE VS TENOFOVIR DISOPROXIL FUMARATE
    Post, Frank
    Sax, Paul
    Saag, Michael
    Yin, Michael
    Oka, Shinichi
    Koenig, Ellen
    Trottier, Benoit
    Andrade, Jaime
    Cao, Huyen
    Fordyce, Marshall
    SEXUALLY TRANSMITTED INFECTIONS, 2015, 91 : A48 - +
  • [30] Tenofovir alafenamide versus tenofovir disoproxil fumarate is there a true difference in safety?
    Pepperrell, T.
    Hughes, S.
    Gotham, D.
    Pozniak, A.
    Boffito, M.
    Pilkington, V.
    Hill, A.
    HIV MEDICINE, 2019, 20 : 92 - 92